Nurse Practitioner in Woodlyn, PA Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Edith Arijaje, Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1860 Plymouth Dr, Woodlyn, PA 19094 Phone: 267-243-4227 |
Dr. Lastasha R Jackson, CRNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 215 Bullens Ln, Woodlyn, PA 19094 Phone: 484-416-0769 |
News Archive
Pioneering clinical trials offers hope to restore damaged cells in Parkinson's disease
The three-part multimillion-pound GDNF study was funded by Parkinson's UK with support from The Cure Parkinson's Trust and in association with the North Bristol NHS Trust.
New data supports safety of ranolazine but not its effectiveness
The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA .
Fred Pritzker calls on meat suppliers to pay medical bills incurred by victims of E. coli
National food safety lawyer Fred Pritzker is calling on National Steak and Poultry company to immediately pay all medical bills and lost wages incurred by victims of a multi-state outbreak of E. coli O157:H7 associated with blade-tenderized steaks.
Seashell study can aid understanding of ancient nervous systems
Determining the evolution of pigmentation patterns on mollusk seashells-which could aid in the understanding of ancient nervous systems-has proved to be a challenging feat for researchers. Now, however, through mathematical equations and simulations, University of Pittsburgh and University of California, Berkeley, researchers have used 19 different species of the predatory sea snail Conus to generate a model of the pigmentation patterns of mollusk shells.
Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
› Verified 9 days ago